𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Angiopoietin-2: Development of inhibitors for cancer therapy

✍ Scribed by Hu, Bo (author);Cheng, Shi Yuan (author)

Publisher
Current Science Inc.
Year
2009
Tongue
English
Weight
270 KB
Volume
11
Category
Article
ISSN
1523-3790

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Development of anaplastic lymphoma kinas
Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy
✍ Rongshi Li; Stephan W. Morris πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 433 KB

## Abstract Anaplastic lymphoma kinase (ALK) is a receptor tyrosine kinase (RTK) involved in the genesis of several human cancers; indeed, ALK was initially identified in constitutively activated and oncogenic fusion formsβ€”the most common being nucleophosmin (NPM)‐ALKβ€”in a non‐Hodgkin's lymphoma (N

Non-peptidic small molecule inhibitors a
Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapy
✍ Asfar S. Azmi; Ramzi M. Mohammad πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 208 KB πŸ‘ 1 views

## Abstract A critical regulator of the apoptotic machinery is the Bcl‐2 family proteins whose over expression confers a protective effect on malignant cells against death signals of apoptosis. Cancer cells that are resistant to various anti‐cancer drugs and treatment regimen are found to over expr